Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | ROCK2 | O75116 | 4/20 | 0.40 |
| ▸ | MMP12 | P39900 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 6/20 | 0.39 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.38 |
| ▸ | METAP1 | P53582 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.37 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9977363 | 0.88 | MAPT (0.49) | ROCK2ALDH1A1LMNANPC1 | |
| SCHEMBL9977364 | 0.88 | MAPT (0.40) | CYP19A1ROCK2MMP12AAK1ALDH1A1 | |
| SCHEMBL25613826 | 0.88 | MAPT (0.53) | CYP19A1ROCK2AAK1ALDH1A1LMNA | |
| SCHEMBL15430125 | 0.88 | HTR2B (0.43) | CYP19A1ROCK2MAOBTERTNPC1 | |
| SCHEMBL26768220 | 0.88 | MAOB (0.42) | ROCK2MAOBAAK1ALDH1A1MEN1 | |
| SCHEMBL18462572 | 0.85 | ROCK2 (0.42) | CYP19A1ROCK2MAOBAAK1MEN1 | |
| SCHEMBL13465062 | 0.85 | LMNA (0.41) | ROCK2AAK1LMNA | |
| SCHEMBL2756745 | 0.85 | LMNA (0.41) | CYP19A1ROCK2MAOBAAK1LMNA | |
| SCHEMBL14985710 | 0.83 | CYP2A6 (0.42) | CYP19A1ROCK2MMP12AAK1LMNA | |
| SCHEMBL15368411 | 0.83 | CYP2A6 (0.42) | CYP19A1ROCK2MMP12MAOBTERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043783-B2 | Liquid crystal composition containing benzochromene compound and use thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2024-07-23 | — | — | US | disclosed |
| US-12043783-B2 | Liquid crystal composition containing benzochromene compound and use thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2024-07-23 | — | — | US | disclosed |
| WO-2023120359-A1 | COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT USING SAME | 住友化学株式会社 | 2023-06-29 | — | — | WO | disclosed |
| WO-2023100844-A1 | COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT EMPLOYING SAME | 住友化学株式会社 | 2023-06-08 | — | — | WO | disclosed |
| US-20230167363-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING BENZOCHROMENE COMPOUND AND USE THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO.,LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20230167363-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING BENZOCHROMENE COMPOUND AND USE THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO.,LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20230148184-A1 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | REMIX THERAPEUTICS INC. | 2023-05-11 | — | — | US | disclosed |
| EP-3966871-B1 | DIAMONDOID COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-05-03 | — | — | EP | disclosed |
| WO-2018100019-A1 | THIOETHER-COMPOUNDS | MERCK PATENT GMBH (DE) | 2018-06-07 | — | — | WO | disclosed |
| US-9981955-B2 | Antiviral compounds | GILEAD PHARMASSET LLC (US) | 2018-05-29 | — | — | US | disclosed |
| EP-2336215-A1 | POLYMER COMPOUND CONTAINING NITROGEN-CONTAINING HETEROCYCLIC STRUCTURE, AND COMPOSITION, SOLUTION, THIN FILM AND POLYMER LIGHT-EMITTING ELEMENT EACH CONTAINING SAME | Sumitomo Chemical Company, Limited (JP) | 2011-06-22 | — | — | EP | disclosed |
| US-20110127517-A1 | COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
| US-20110127517-A1 | COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
| US-20110127516-A1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL COMPANY ,LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
| US-20110127516-A1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL COMPANY ,LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
| EP-2311893-A1 | COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME | Sumitomo Chemical Company, Limited (JP) | 2011-04-20 | — | — | EP | disclosed |
| EP-2308910-A1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | Sumitomo Chemical Company, Limited (JP) | 2011-04-13 | — | — | EP | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| WO-2010132601-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110127516-A1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | RER1, NAP1L1, CRY1 | CYP19A1 1995/4885ROCK2 2583/4885MMP12 4641/4885 |
| US-20230148184-A1 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | RBM17, SNRPA, SNRPA1 | CYP19A1 2976/4885ROCK2 3891/4885MMP12 3913/4885 |
| US-20110127517-A1 | COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME | KCNMA1, KCNA1, KCNJ11 | CYP19A1 513/4885ROCK2 2886/4885MMP12 4790/4885 |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | CYP19A1 4579/4885ROCK2 4091/4885MMP12 2370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.